Patent · US Active

Substituted N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-D]pyrimidine-4-amine as janus kinase inhibitor

US10081635B2 · kind B2 · utility

1Cited by
0References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 25, 2015
Grant dateSep 25, 2018
Priority date—
Expiry dateAug 25, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A novel substituted N-(pyrrolidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine and a use thereof as a Janus kinase (JAK) inhibitor are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.